Abcam reports another year of growth
Abcam plc, a global leader in the supply of life science research tools, announces the following pre-close trading update ahead of its results for the financial year ended 30 June 2015 [1].
Abcam appoints Suzanne Smith as Chief Legal Officer and Company Secretary
Abcam plc, a global leader in the supply of life science research tools, announces that it has appointed Suzanne Smith in the new role of Chief Legal Officer and Company Secretary, based at Abcam’s headquarters in Cambridge, UK, effective from 6 July 2015. Accordingly, Jeff Iliffe will resign from the role of Company Secretary with effect from the same date.
Abcam launches multiplex miRNA profiling assays
Abcam plc, a global leader in the supply of life science research tools, announced today the launch of a range of multiplex miRNA profiling assays for high-throughput validation of miRNA biomarkers, based on Abcam’s new Firefly™ particle technology.
Abcam's Scientist of the Month: Marianne Rots
Marianne Rots, Professor of Molecular Epigenetics at the University Medical Center, Groningen, discusses her exciting research on epigenetic editing.
Abcam acquires Firefly BioWorks to expand capabilities in multiplex analysis
Abcam plc, a global leader in the supply of life science research tools, today announces that it has entered into a definitive agreement to acquire the entire issued share capital of Firefly BioWorks Inc on a cash-free/debt-free basis for £18.5m ($28.0m).
Abcam partners with A*STAR’s Institute of Molecular and Cell Biology
Abcam plc, a global leader in the supply of life science research tools, announced today it has signed an exclusive partnership agreement with the Institute of Molecular and Cell Biology (IMCB), a research institute under the Agency for Science, Technology and Research (A*STAR), Singapore.
Abcam's Scientist of the Month: Katharine Wrighton
Have you ever wondered what it is like to be an editor at a high impact journal? Katharine Wrighton, Chief Editor of Nature Reviews Molecular Cell Biology, talks about her journey from laboratory to editorial office.
Abcam appoints Yvonne Chien as Chief Digital Officer
Abcam plc, a global leader in the supply of protein research tools and services, announced today that it has appointed Yvonne Chien as Chief Digital Officer. The Company also announced the appointment of Sue Harris as non-Executive Director to the Abcam Board, further strengthening Abcam’s leadership team.
Abcam plc announces Board appointment
Abcam plc, a global leader in the supply of life science research tools, is pleased to announce the appointment of Sue Harris as a non-Executive Director on the Abcam Board. Sue will join the Board with immediate effect and will Chair the Audit Committee.
Abcam's Scientist of the Month: Esteban Ballestar
Esteban Ballestar tells Abcam about work in his lab focusing on active DNA methylation, and what new developments might feature in the upcoming webinar on DNA methylation during cell differentiation.
Abcam wins ‘Best use of digital media’ at Life Science Industry Awards
Abcam plc., a leading provider of protein research tools and services, announced today that it has won the Life Science Industry Award for the ‘Best use of digital media’.
Abcam Events: 10 year anniversary giveaway
November 2014 is Abcam Events’ 10 Year Anniversary!
Abcam's Scientist of the Month: John Gurdon
Professor Sir John Gurdon took some time away from his busy schedule to tell Abcam about his current research interests and thoughts on the future of epigenetics research.
Abcam plc announces appointment of new CEO and Board changes
Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, is pleased to announce the appointment of Alan Hirzel as Chief Executive Officer with immediate effect. Alan will succeed long-serving Chief Executive and co-Founder of Abcam Jonathan Milner, who will continue to play an active role in the Company as Deputy Chairman and who remains the Company's largest…
Abcam introduces exclusive range of highly validated antibody conjugates
Abcam plc, a leading provider of protein research tools and services, announced today it has launched an exclusive range of highly validated conjugated antibodies for use in key imaging applications including immunofluorescence, flow cytometry, and fluorescent western blotting.
Abcam establishes new direct service for Australia and New Zealand
Abcam plc, a global leader in the supply of innovative protein research tools, announced today it has established a direct service to Australia and New Zealand. The move signifies the importance of this region and Abcam’s focus on providing the best products and services to accelerate the pace of researchers’ scientific discoveries.
Abcam’s CEO wins European Mediscience Award
Abcam plc., a leading provider of innovative protein research tools and services, is pleased to announce that its CEO, Dr Jonathan Milner, has won the European Mediscience award for the ‘Most significant contribution to the Mediscience sector’.
'Exciting times' for Abcam as results are published
Abcam plc (AIM: ABC), a global leader in the supply of innovative protein research tools, is pleased to announce its interim results for the six months ended 31 December 2013.
Abcam announces winner of 15 discoveries contest
Abcam plc, a global leader in the supply of innovative protein research tools, today announced Yali Huang as the winner of its 15 discoveries contest. Ms. Huang conducts her work at the Early Embryo Development lab at the MRC Centre of Regenerative Medicine, University of Edinburgh, Scotland. The contest recognises the most innovative and exciting scientific breakthroughs of the last 18 months…
Abcam to open office in Shanghai, China
Abcam plc, a global leader in the supply of innovative protein research tools, has announced that it will open a new office in February 2014, in Shanghai, China. The new hub is the Company’s ninth global office, and has been established to support Abcam’s focus on increasing geographic reach and improving distribution channels to rapidly growing markets.
Abcam named AIM 'Company of the Year'
Abcam Plc., a leading provider of life science research tools, announced today it has been named ‘Company of the Year’ in the 2013 AIM Awards. The AIM awards celebrate outstanding achievement of quoted companies and entrepreneurs who have harnessed AIM to help them fulfil their ambition and growth potential in the last twelve months.
Abcam launches SimpleStep ELISA kits
Abcam plc., a producer and distributor of high quality protein research tools, announced today that it has launched a range of SimpleStep™ ELISA kits. The new kits have a greatly simplified protocol when compared to standard multi-step ELISAs, providing significant time savings and ease of use.
Abcam appoints Alan Hirzel as Chief Marketing Officer
Abcam, a global leader in the supply of protein research tools, announced today that it has appointed Alan Hirzel as Chief Marketing Officer. This is a new position, based at Abcam’s Headquarters in Cambridge, which will strengthen Abcam’s management team and support the company in delivering its growth strategies.
Abcam signs licence agreement with Pfizer to supply compounds to researchers
Abcam Plc., a producer and distributor of high quality protein research tools, announced today that it has entered into a licence agreement with Pfizer. Under the terms of the agreement, Abcam’s Biochemicals division will supply a range of authentic Pfizer compounds for use as pre-clinical research tools by researchers worldwide, alongside the Abcam Biochemicals range of over 2000 bioactive…
Abcam licenses novel technology from Columbia University for neurobiological research
Bristol and Cambridge, UK, April 08, 2013 Abcam Plc., a producer and distributor of high quality protein research tools, and Columbia University announced today that they have entered into an exclusive licence agreement for two novel pH-responsive fluorescent false neurotransmitters (FFNs). FFNs are probes which act as optical tracers, allowing imaging of neurotransmitter release from individual…